Crossmark

Biological evaluation of imidazopyridine derivatives as potential anticancer agents against breast cancer cells

Published Online: 2022-10-26

Published Print: 2022-12

Authors

Sucu, Bilgesu Onur https://orcid.org/0000-0003-0957-6965
License Information

Text and Data Mining valid from 2022-10-26

Version of Record valid from 2022-10-26
More Information

Article History

Received: 4 June 2022

Accepted: 10 October 2022

First Online: 26 October 2022

Compliance with ethical standards

:

: The author declares no competing interests.

Document is current